Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 761 - 780 results of 102,316 for search '(( 5 a decrease ) OR ( 5 ((((step decrease) OR (we decrease))) OR (mean decrease)) ))', query time: 1.79s Refine Results
  1. 761
    Intranasal administration of telmisartan decreases amyloid plaques and CD11b staining in the cortex of 3-month-old 5XFAD mice.

    Intranasal administration of telmisartan decreases amyloid plaques and CD11b staining in the cortex of 3-month-old 5XFAD mice. by Nofar Torika (3169497)

    Published 2016
    Save to List
    Saved in:
  2. 762
    Hepatic irradiation decreases the proportion of DX5<sup>–</sup>TRAIL<sup>+</sup> lrNK cells for up to two months.

    Hepatic irradiation decreases the proportion of DX5<sup>–</sup>TRAIL<sup>+</sup> lrNK cells for up to two months. by Ryosuke Nakano (4557097)

    Published 2018
    “…NK cells were divided into DX5<sup>–</sup>TRAIL<sup>+</sup> lrNK cells and DX5<sup>+</sup>TRAIL<sup>−</sup> cNK cells. …”
    Save to List
    Saved in:
  3. 763
    Cell adhesion was decreased by simvastatin and benznidazole during <i>Trypanosoma cruzi</i> infection.

    Cell adhesion was decreased by simvastatin and benznidazole during <i>Trypanosoma cruzi</i> infection. by Carolina Campos-Estrada (403914)

    Published 2015
    Save to List
    Saved in:
  4. 764
    (A) Procedural steps for minimally invasive Ponto surgery (MIPS). The MIPS procedure involves the following steps: (i) A circular incision is created at the selected site via a 4- or 5-mm biopsy punch. (ii) The periosteum around the surgical site is removed. (iii) The cannula is inserted into the incision. (iv) First, initial guide drilling is performed. (v) If the bone thickness is adequate, the spacer should be removed from the guide drill to prepare for a 4-mm implant. (vi) The hole is widened with a widening drill. (vii) The cannula is removed, and the implant is installed through the circular incision. (viii) Finally, a soft healing cap is attached to the abutment, and a dressing is applied. (B) The surgical steps for the MONO procedure. The MONO procedure involves the following steps: (i) Create a circular incision at the chosen site via a 4- or 5-mm biopsy punch. (ii) The periosteum around the surgical site is removed. (iii) The cannula is inserted into the incision. (iv) Th

    (A) Procedural steps for minimally invasive Ponto surgery (MIPS). The MIPS procedure involves the following steps: (i) A circular incision is created at the selected site via a 4-... by Marsel Ganeyev (21453399)

    Published 2025
    Save to List
    Saved in:
  5. 765
    Focal adhesion kinase phosphorylation levels within the optic nerve head decrease steadily after intraocular pressure elevation.

    Focal adhesion kinase phosphorylation levels within the optic nerve head decrease steadily after intraocular pressure elevation. by Shandiz Tehrani (3365900)

    Published 2016
    Save to List
    Saved in:
  6. 766
    One-step growth cycle of CVB3 wild type and M1-M6 mutant viruses in HeLa cells.

    One-step growth cycle of CVB3 wild type and M1-M6 mutant viruses in HeLa cells. by Jawhar Gharbi (11492361)

    Published 2022
    Save to List
    Saved in:
  7. 767
    Sign-tracking (ST)–Goal-tracking (GT) score for day 5.

    Sign-tracking (ST)–Goal-tracking (GT) score for day 5. by Silvia Fuentes (4759686)

    Published 2018
    Save to List
    Saved in:
  8. 768
    Decreased ratio of GSH/GSSG in <i>Slc1a1-</i>HET mice.

    Decreased ratio of GSH/GSSG in <i>Slc1a1-</i>HET mice. by Parisa Afshari (4423141)

    Published 2017
    Save to List
    Saved in:
  9. 769
    Mucosal vaccination with M2e5x VLP decreases innate immune cell recruitments after influenza virus infection.

    Mucosal vaccination with M2e5x VLP decreases innate immune cell recruitments after influenza virus infection. by Young-Tae Lee (467116)

    Published 2018
    Save to List
    Saved in:
  10. 770
    Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis

    Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis by Romy M. W. Kremers (819412)

    Published 2017
    Save to List
    Saved in:
  11. 771
    Study Flow Diagram.

    Study Flow Diagram. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 772
    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90.

    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 773
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 774
    Antibody and antigen responses to Ensovibep vs placebo day 1–90.

    Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 775
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 776
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 777
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 778
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 779
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 780
    Long-term anti-nucleocapsid response by baseline patient characteristics.

    Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: